Table 2 of Chua, Mol Vis 2012; 18:431-438.


Table 2. Aqueous cytokine concentrations in glaucoma and non-glaucomatous cataract groups.

  Cataract (n=23) Glaucoma (n=38)    
Cytokines Median Range Measurable Median Range Measurable p-valuea Sensitivity
IL-2* 2.16 0–8 14/23 3.01 0–27 34/38 0.154 1.6
IFN-γ* 12.73 0–91 12/23 26.98 0–1167 36/38 0.002 6.4
IL-13 3.85 0–8 19/23 4.82 0–46 35/38 0.432 0.7
IL-17 2.27 0–11 8/23 3.98 0–241 22/38 0.227 3.3
IL-6* 2.23 0–14 9/23 4.02 0–89 27/38 0.789 2.6
IL-10* 1.45 0–5 18/23 1.91 0–64 37/38 0.050 0.3
IL-12* 7.15 0–27 17/23 14.06 0–68 36/38 0.003 3.5
IL-1β* 0.60 0–6 14/23 0.72 0–5 33/38 1.000 0.6
TNF-α* 9.58 0–34 16/23 12.65 0–82 35/38 0.086 6.0
IL-1Ra 8.58 3–96 10/17 8.74 0–84 14/34 1.000 5.5
IL-15 8.50 6–29 17/17 9.00 0–26 33/34 1.000 2.4
IFN-α* 26.24 0–139 16/22 37.90 0–311 37/38 0.034 4.3
CCL2 180.89 32–962 23/23 295.22 0–1072 37/38 0.086 1.1
CCL4 16.94 4–137 23/23 33.06 1–229 37/38 0.056 2.4
CCL5 6.30 0–25 16/17 6.30 0–39 33/34 1.000 1.8
CCL11 4.90 0–10 12/17 5.50 0–17 29/34 1.000 2.5
CXCL8 3.08 1–20 22/23 5.58 0–81 36/38 0.060 1.0
CXCL9* 62.20 0–3603 18/20 214.97 21–1351 38/38 0.006 1.2
CXCL10 56.27 0–5038 20/22 147.93 0–4677 37/38 0.290 6.1
IL-7* 1.09 0–15 10/23 1.92 0–4 31/38 0.728 1.1
IL-9* 5.50 0–11 15/17 7.57 0–17 33/34 0.032 2.5
GM-CSF* 135.45 0–766 18/23 164.05 0–6815 37/38 0.301 2.2
PDGF-BB 3.11 0–14 11/17 2.26 0–9 27/34 1.000 2.9
Basic-FGF 10.62 7–44 17/17 11.39 0–35 33/34 1.000 1.9
VEGF 43.73 22–124 17/17 54.35 0–151 33/34 1.000 3.1